These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12369233)

  • 1. Variation in average costs among federally sponsored state-organized cancer detection programs: economies of scale?
    Mansley EC; Duñet DO; May DS; Chattopadhyay SK; McKenna MT
    Med Decis Making; 2002; 22(5 Suppl):S67-79. PubMed ID: 12369233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economies of scale in federally-funded state-organized public health programs: results from the National Breast and Cervical Cancer Early Detection Programs.
    Trogdon JG; Ekwueme DU; Subramanian S; Crouse W
    Health Care Manag Sci; 2014 Dec; 17(4):321-30. PubMed ID: 24326873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumer-Operated Service Programs: monetary and donated costs and cost-effectiveness.
    Yates BT; Mannix D; Freed MC; Campbell J; Johnsen M; Jones K; Blyler CR
    Psychiatr Rehabil J; 2011; 35(2):91-9. PubMed ID: 22020838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing and testing a cost-assessment tool for cancer screening programs.
    Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
    Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.
    Trogdon JG; Ekwueme DU; Subramanian S; Miller JW; Wong FL
    Cancer Causes Control; 2019 Aug; 30(8):813-818. PubMed ID: 31187351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
    Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost and efficiency of public and private health care facilities in Ogun State, Nigeria.
    Wouters A
    Health Econ; 1993 Apr; 2(1):31-42. PubMed ID: 8269045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
    Marseille E; Dandona L; Marshall N; Gaist P; Bautista-Arredondo S; Rollins B; Bertozzi SM; Coovadia J; Saba J; Lioznov D; Du Plessis JA; Krupitsky E; Stanley N; Over M; Peryshkina A; Kumar SG; Muyingo S; Pitter C; Lundberg M; Kahn JG
    BMC Health Serv Res; 2007 Jul; 7():108. PubMed ID: 17626616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying and controlling for program-level differences in comparative cost analysis: lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program.
    Subramanian S; Ekwueme DU; Gardner JG; Bapat B; Kramer C
    Eval Program Plann; 2008 May; 31(2):136-44. PubMed ID: 18359084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
    Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
    Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.
    Boulle A; Kenyon C; Skordis J; Wood R
    S Afr Med J; 2002 Oct; 92(10):811-7. PubMed ID: 12432807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the effectiveness of disease and injury prevention programs: costs and consequences.
    MMWR Recomm Rep; 1995 Aug; 44(RR-10):1-10. PubMed ID: 7565538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awardee-specific economic costs of providing cancer screening and health promotional services to medically underserved women eligible in the National Breast and Cervical Cancer Early Detection Program.
    Subramanian S; Ekwueme DU; Miller JW; Khushalani JS; Trogdon JG; Wong FL
    Cancer Causes Control; 2019 Aug; 30(8):827-834. PubMed ID: 31111278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cost of screening for breast and cervical cancer in France].
    Watt S
    Bull Cancer; 2003 Nov; 90(11):997-1004. PubMed ID: 14706904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rationing in German health care with particular consideration of oncology: view points of German stakeholders--a qualitative interview study].
    Lange J; Gönner C; Vollmann J; Rauprich O
    Gesundheitswesen; 2015 Jan; 77(1):8-15. PubMed ID: 24696371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
    Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of HIV services in Nigeria: Determinants of unit cost variation of HIV counseling and testing and prevention of mother-to-child transmission interventions.
    Bautista-Arredondo S; La Hera-Fuentes G; Contreras-Loya D; Kwan A; Van Buren SJ; Amanze OO; Atobatele A; Adeyemi A; Abatta E; Ogungbemi KM; Sosa-Rubí SG
    PLoS One; 2018; 13(9):e0201706. PubMed ID: 30192765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient navigation for breast and colorectal cancer in 3 community hospital settings: an economic evaluation.
    Donaldson EA; Holtgrave DR; Duffin RA; Feltner F; Funderburk W; Freeman HP
    Cancer; 2012 Oct; 118(19):4851-9. PubMed ID: 22392629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.